The triple therapy of metformin, a DPP-4 inhibitor and a SGLT-2 inhibitor has a very low treatment related hypoglycaemia risk, leads to a further, almost additive reduction of glycaemic parameters, a body weight loss in the same range as with a mono- or dual therapy with a SGLT-2 inhibitor and also to the expected SGLT-2 inhibitor induced reduction of blood pressure
People often ask how fast weight loss happens
In this analysis, results suggested use was associated with resolution of liver fat in more than 85% of patients
Combining these effects generously suggests 5-8 pounds of potential weight loss, assuming optimal doses and individual responsiveness
Inositol: Often grouped with B vitamins, inositol supports the breakdown of fats and helps the liver export lipids
The answer: Yes, but not on its own